General rules of the management of diabetes with psychiatric disorders

##plugins.themes.academic_pro.article.sidebar##

Published Apr 20, 2012
Download
pdf
Vol. 90 No. 4 (2012): Issue Apr 2012

##plugins.themes.academic_pro.article.main##

Naziha Khammassi
Abdelhedi Haykel
Ouahida Cherif

Abstract

Background: Psychiatric disorders appear to be frequent in patients with diabetes mellitus. The presence of psychiatric co-morbidity may affect adherence to medication and self-care regimes.
Aim: To establish rules of the management of diabetes among people with psychiatric disorders.
Methods: Literature review on the PUBMED database using the following keywords: diabetes, psychiatric disorders, anti-psychotics, complications.
Results: Psychiatric disorders appear to be frequent in patients with diabetes mellitus. Their presence is associated with poor glycemic control and more diabetes complications. This negative effect may be increased by taking atypical antipsychotics which expose to several metabolic effects such as overweight, insulin resistance, hyperglycemia, Type 2 diabetes and dyslipidemia.
Conclusion: The management of diabetes among people with psychiatric disorders should be multidisciplinary including internist, diabetologist, psychiatrist, and paramedical staff. This treatment includes medical (anti-diabetics, anti-psychotics) and psychotherapeutic interventions through which we can have better glycemic control and decreased rates of diabetes complications.

Keywords:

Diabetes; psychiatric disorders; anti-psychotics; psychotherapy; complications

##plugins.themes.academic_pro.article.details##

References

  1. Kaholokula JK; Schirmer TN; Elting D. Identifying and prioritizing diabetes care issues among mental health professionals of a multi-ethnic, state psychiatric hospital. Diabetes Spectrum 2004; 17: 123-128.
  2. Jacobson AM. The psychological care of patients with insulindependent diabetes mellitus. NEJM 1996; 334: 1249-1253.
  3. Edge LE. Effect of Comorbid Chronic Diseases on Prevalence and Odds of Depression in Adults with Diabetes. Psychosom Med 2005; 67:46-51.
  4. Stewart SM, Rao U, Emslie GJ, Klein D, White PC. Depressive Symptoms Predict Hospitalization for Adolescents With Type 1 Diabetes Mellitus. Pediatrics 2005; 115: 1315-1319.
  5. American diabetes Association, American Psychiatric Association, American Association of clinical Endocrinologists, North American Association for the study of Obesity. Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes. Diabetes Care 2004; 27: 596-601
  6. Llorente MD, Urrutia V. Diabetes, Psychiatric Disorders, and the Metabolic Effects of Antipsychotic Medications. Clinical diabetes 2006; 24: 18-24.
  7. De Hert M, Hassens L, Van Winkel R et al. Reversibility of Antipsychotic Treatment-Related Diabetes in Patients with Schizophrenia. Diabetes Care 2006; 29 : 2329-30.
  8. Istikoglou C, Mikirditsian O, Michelidakis C, Golfinopoulos G, Stathaki M, Vlissides D. Diabetes and atypical antipsychotics. Ann Gen Psychiatry 2008; 7 (Suppl 1): 105.
  9. Sullivan G, Han X, Susan Moore S, Kotrla K. Disparities in Hospitalization for Diabetes among Persons With and Without Cooccurring Mental Disorders. Psychiatr Serv 2006; 57:1126-1131
  10. Aspects psychologiques du diabète. Association canadienne du diabète Comité d'experts des Lignes directrices de pratique clinique 2003 : 56-57.
  11. MC Welschen L, van Oppen P, Dekker JM, Bouter LM, Stalman WAB, Nijpels G. The effectiveness of adding cognitive behavioural therapy aimed at changing lifestyle to managed diabetes care for patients with type 2 diabetes: design of a randomised controlled trial. BMC Public Health 2007; 74: 1-10.
  12. Lakerveld J, Bott SDM, Chinapaw MJ. Primary prevention of diabetes mellitus type 2 and cardiovascular diseases using a cognitive behaviour program aimed at lifestyle changes in people at risk: Design of a randomized controlled trial. BMC Endocr Disord 2008; 6: 1-11
  13. Lefebvre N, Chéreau I, Schmitt A, Llorca PM. Comorbidités somatiques chez les patients souffrant de schizophrénie traitée. Recommandations actuelles. Ann Med Psychol 2006; 164: 159-64.
  14. Scheen AJ, De Hert MA. Abnormal glucose metabolism in patients treated with antipsychotics. Diabetes Metab 2007; 33: 169-75.
  15. Gaston RL, George M, Azhahan N. Diabetic control and atypical antipsychotics: a case report. J Med Case Reports 2008; 155: 1-4.
  16. Nasrallah HA, Meyer JM, Goff DC et al. Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: Data from the CATIE schizophrenia trial sample at baseline. Schizophr Res 2006; 86: 15-22.
  17. Cohen D, Stolk RP, Grobblef DE, Gispen-De Wied CG. Hyperglycemia and Diabetes in Patients with Schizophrenia or Schizoaffective Disorders. Diabetes Care 2006; 29: 786-791.
  18. Jindal RD, Keshavan MS. Hyperglycemia and Diabetes in Patients with Schizophrenia or Schizoaffective Disorders Response to Cohen et al. Diabetes Care 2007; 30: 786-791.